The present invention relates to a composition comprising a) a B subunit of Shiga toxin or a functional equivalent thereof which is able to bind the Gb3 receptor, complexed with an antigen and b) at least one ligand of CD1 capable of stimulating NK T cells; and to a pharmaceutical composition and a medicament comprising said composition.